IgA, Heavy Chain

Référence I1890-65A-250ug

Conditionnement : 250ug

Marque : US Biological

Contactez votre distributeur local :


Téléphone : +1 850 650 7790


I1890-65A IgA, Heavy Chain

Clone Type
Monoclonal
Host
mouse
Source
rat
Isotype
IgG1
Grade
Affinity Purified
Applications
E IF IHC
Crossreactivity
Rt
Shipping Temp
Blue Ice
Storage Temp
-20°C

Applications:
Suitable for use in ELISA, Immunofluorescence and Immunohistochemistry. Other applications have not been tested.

Recommended Dilutions:
ELISA: 5ug/ml as coating antibody
Immunohistochemistry: Frozen sections
Optimal working dilutions to be determined by researcher.

Hybridoma:
Spleen cells from immunized BALB/c mice were fused with cells of the mouse SP2/0 myeloma cell line.

Matched Pair:
Capture: I1890-65A
Detection: K0100-01B

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months after receipt. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Applications
Product Type: Mab|Isotype: IgG1|Clone No: 3H2263 (MARA-1)|Host: mouse|Source: rat|Concentration: ~1mg/ml|Form: Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.|Purity: Purified by affinity chromatography from tissue culture supernatant.|Immunogen: Purified IR1060 IgA rat myeloma protein.|Specificity: Recognizes the alpha heavy chain of rat immunoglobulin. No crossreactivity with other rat immunoglobulin classes. ||Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.
Immunogen
Purified IR1060 IgA rat myeloma protein.
Form
Supplied as a liquid in PBS, pH 7.2, 0.09% sodium azide.
Purity
Purified by affinity chromatography from tissue culture supernatant.
Specificity
Recognizes the alpha heavy chain of rat immunoglobulin. No crossreactivity with other rat immunoglobulin classes.
References
1. Bjersing, J.L. et al. (2002) Clin Exp Immunol. 130: 404-8. 2. Budec, M. et al. (2007) Int Immunopharmacol. 7: 858-63. 3. Budec, M. et al. (2009) Neuroimmunomodulation. 16: 155-61. 4. Hahn, A. et el. (2010) Immunology. 129: 427-36. 5. Herías, M.V. et al. (1999) Clin Exp Immunol. 11 J Agric Food Chem. Apr 21. [Epub ahead of print] 7. Kushnir, N. et al. (1998) J Immunol. 160: 1774-81.